{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:05:20Z","timestamp":1789182320103,"version":"build-2803163510"},"reference-count":53,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Long\u2010acting cabotegravir\/rilpivirine (LA\u2010CAB\/RPV) is currently approved as a switch strategy in people living with HIV virally suppressed on oral antiretroviral therapy. Although small reports on specific, difficult\u2010to\u2010treat populations demonstrated the efficacy of LA\u2010CAB\/RPV in people living with HIV and unsuppressed viraemia, cumulative data on this issue are still lacking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a systematic review and meta\u2010analysis based on PRISMA guidelines using PubMed, Scopus, Google Scholar and Medline, including papers or abstracts that evaluated the use of LA\u2010CAB\/RPV in viraemic people living with HIV. Two papers were excluded as they reported only single clinical cases; one study was excluded for including only three perinatally infected subjects. Two papers were reviews and two papers and one abstract reported result from Ward 86, which were later included in a final paper. One paper presenting preliminary results from the OPERA cohort was excluded, as these data were subsequently updated. The ACTG LATITUDE (A5359) study was not included, as it did not specifically report outcomes for people living with HIV who initiated LA\u2010CAB\/RPV while viraemic. After applying these selection criteria, five papers and three abstracts were included in the meta\u2010analysis. The main outcome was virologic success, as defined by each individual study, in people living with HIV with at least one HIV\u2010RNA evaluation after initiating LA\u2010CAB\/RPV. We did not perform a meta\u2010analysis on other variables due to inconsistent assessment across studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, 244 people living with HIV started LA\u2010CAB\/RPV when viraemic. Most of them reported adherence, psychological or social issues that limited compliance to standard oral treatment. The cumulative probability of achieving virologic success was 87% (79%\u201395%). Most patients maintained adherence rates above 90% to their scheduled injection visits. Eleven patients living with HIV developed RPV\u2010associated mutations and five CAB\u2010associated mutations at virologic failure. No interruption of LA\u2010CAB\/RPV for adverse events was reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This is the first meta\u2010analysis that assessed the efficacy of LA\u2010CAB\/RPV in viraemic people living with HIV; oral treatment efficacy was jeopardized by low compliance due to adherence or psychological issues. Our results can justify the use of LA\u2010CAB\/RPV also in viraemic patients without alternative oral options.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hiv.70025","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T01:38:53Z","timestamp":1744249133000},"page":"993-1003","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy of long\u2010acting cabotegravir plus rilpivirine in viraemic people living with <scp>HIV<\/scp>: A systematic review and meta\u2010analysis"],"prefix":"10.1111","volume":"26","author":[{"given":"Beatrice","family":"Barda","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases Ente Ospedaliero Cantonale  Lugano Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Barilaro","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Sant'Eugenio Hospital  Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Bellini","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Ente Ospedaliero Cantonale  Lugano Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Turicchi","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Ente Ospedaliero Cantonale  Lugano Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enos","family":"Bernasconi","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Ente Ospedaliero Cantonale  Lugano Switzerland"},{"name":"University of Southern Switzerland  Lugano Switzerland"},{"name":"University of Geneva  Geneva Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2999-3707","authenticated-orcid":false,"given":"Marco","family":"Bongiovanni","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Ente Ospedaliero Cantonale  Lugano Switzerland"},{"name":"University of Southern Switzerland  Lugano Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1909512"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1904398"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352\u20103018(21)00185\u20105"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(21)00184-3"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003025"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352\u20103018(23)00136\u20104"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473\u20103099(24)00289\u20105"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae557"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000904"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26394"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00880\u201024"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14081588"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352\u20103018(23)00300\u20104"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2023.0057"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003273"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12981\u2010022\u201000477\u2010w"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac631"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.7326\/M23\u20100788"},{"key":"e_1_2_10_20_1","unstructured":"HickeyMD GrochowskiJ Mayorga\u2010MunozF et al.24\u2010week viral suppression in patients starting long\u2010acting CAB\/RPV without HIV viral suppression. Conference on Retrovirus and Opportunistic Infections Denver 3\u20136 March 2024 Abstract 628.2024."},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121\u2010023\u201000890\u20102"},{"key":"e_1_2_10_22_1","unstructured":"RanaA BaoY ZhengL et al.Long\u2010acting injectable CAB\/RPV is superior to oral ART in PWH with adherence challenges (late breaker abstract). Conference on Retrovirus and Opportunistic Infections Denver 3\u20136 March 2024 Abstract 212.2024."},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae500"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad511"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piae033"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13370"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae125"},{"key":"e_1_2_10_28_1","unstructured":"ElionRA FrickA RadtchenkoJ et al.Real\u2010world utilization and effectiveness of long\u2010acting cabotegravir and rilpivirine among people with HIV with detectable viral loads at initiation: TRIO cohort study. ID Week 2023. Boston 11\u201315 October 2023.2023."},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad500.059"},{"key":"e_1_2_10_30_1","article-title":"Clinical outcome at month 12 after initiation of cabotegravir and rilpivirine long\u2010acting (CAB+RPV LA) in an observational real\u2010world study (BEYOND)","author":"Schneider S","year":"2024","journal-title":"AIDS"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/2049\u20103258\u201072\u201039"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(18)30092-4"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(18)30091-2"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(13)61221\u20100"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461\u2010019\u201002704\u20104"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.2985"},{"key":"e_1_2_10_37_1","unstructured":"NIH.What's New: Adult and Adolescent ARV HIV Clinical Guidelines.2024.https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-arv\/whats-new"},{"key":"e_1_2_10_38_1","unstructured":"https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/progress-towards-95-95-95_en.pdf"},{"key":"e_1_2_10_39_1","unstructured":"https:\/\/www.unaids.org\/sites\/default\/files\/2025-AIDS-Targets_en.pdf"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen\u20102022\u2010070666"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2022.0168"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad370"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(17)32340\u20101"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(17)32299\u20107"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215541"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(12)61853\u20104"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab297"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa202"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000003320"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae475"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae616"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100793"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae016"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae023"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hiv.70025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T10:46:02Z","timestamp":1751366762000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hiv.70025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1111\/hiv.70025"],"URL":"https:\/\/doi.org\/10.1111\/hiv.70025","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"2025-02-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}